Cargando…

Association study of the excitatory amino acid transporter 2 (EAAT2) and glycine transporter 1 (GlyT1) gene polymorphism with schizophrenia in a Polish population

Background: Excitatory amino acid transporter 2 encoded by SLC1A2 is responsible for approximately 90% of glutamate uptake. Glycine transporter 1, encoded by SLC6A9, is responsible for maintaining a low concentration of the N-methyl-D-aspartate receptor (NMDAR) co-agonist – glycine in the synaptic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Merk, Wojciech, Kucia, Krzysztof, Mędrala, Tomasz, Kowalczyk, Małgorzata, Owczarek, Aleksander, Kowalski, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499478/
https://www.ncbi.nlm.nih.gov/pubmed/31118638
http://dx.doi.org/10.2147/NDT.S194924
_version_ 1783415799581507584
author Merk, Wojciech
Kucia, Krzysztof
Mędrala, Tomasz
Kowalczyk, Małgorzata
Owczarek, Aleksander
Kowalski, Jan
author_facet Merk, Wojciech
Kucia, Krzysztof
Mędrala, Tomasz
Kowalczyk, Małgorzata
Owczarek, Aleksander
Kowalski, Jan
author_sort Merk, Wojciech
collection PubMed
description Background: Excitatory amino acid transporter 2 encoded by SLC1A2 is responsible for approximately 90% of glutamate uptake. Glycine transporter 1, encoded by SLC6A9, is responsible for maintaining a low concentration of the N-methyl-D-aspartate receptor (NMDAR) co-agonist – glycine in the synaptic cleft, suggesting its participation in the development of the NMDARs hypofunction described in schizophrenia. Aim: The aim of this study was to evaluate whether the functional polymorphism-181 A/C (rs4354668) of the SLC1A2 and the rs2486001 (IVS3+411 G/A) in the SLC6A9 are involved in schizophrenia development and its clinical picture in the Polish population. Methods: The study group consisted of 393 unrelated Caucasian patients (157 [39.9%] females and 236 [60.1%] males; mean age 41±12) diagnosed with schizophrenia according to the DSM-5, and 462 healthy controls. The results of the Positive and Negative Syndrome Scale (PANSS) were presented in the five-dimensional model. Polymorphisms of SLC1A2 and SLC6A9 were genotyped with the use of PCR-RFLP assay. Results: There were no statistically significant differences in the frequency of genotypes and alleles between the patients and controls for SLC1A2 and SLC6A9 polymorphisms in either the entire sample or after stratification according to gender. In the haplotype analysis, men with CA haplotype had more than 1.5 higher risk to develop schizophrenia than women (OR=1.63 [95% CI=1.17–2.27, p<0.05]). The influence of gender, genotypes of both analyzed polymorphisms and gender x genotype interactions on individual dimensions of the PANSS scale has not been observed. Also, there was no association of either polymorphism with suicide attempts. Conclusion: The results of the present study did not indicate an association of polymorphism-181 A/C (rs4354668) in SLC1A2 and rs2486001 in SLC6A9 with onset of schizophrenia and its psychopathology in a Polish population.
format Online
Article
Text
id pubmed-6499478
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-64994782019-05-22 Association study of the excitatory amino acid transporter 2 (EAAT2) and glycine transporter 1 (GlyT1) gene polymorphism with schizophrenia in a Polish population Merk, Wojciech Kucia, Krzysztof Mędrala, Tomasz Kowalczyk, Małgorzata Owczarek, Aleksander Kowalski, Jan Neuropsychiatr Dis Treat Original Research Background: Excitatory amino acid transporter 2 encoded by SLC1A2 is responsible for approximately 90% of glutamate uptake. Glycine transporter 1, encoded by SLC6A9, is responsible for maintaining a low concentration of the N-methyl-D-aspartate receptor (NMDAR) co-agonist – glycine in the synaptic cleft, suggesting its participation in the development of the NMDARs hypofunction described in schizophrenia. Aim: The aim of this study was to evaluate whether the functional polymorphism-181 A/C (rs4354668) of the SLC1A2 and the rs2486001 (IVS3+411 G/A) in the SLC6A9 are involved in schizophrenia development and its clinical picture in the Polish population. Methods: The study group consisted of 393 unrelated Caucasian patients (157 [39.9%] females and 236 [60.1%] males; mean age 41±12) diagnosed with schizophrenia according to the DSM-5, and 462 healthy controls. The results of the Positive and Negative Syndrome Scale (PANSS) were presented in the five-dimensional model. Polymorphisms of SLC1A2 and SLC6A9 were genotyped with the use of PCR-RFLP assay. Results: There were no statistically significant differences in the frequency of genotypes and alleles between the patients and controls for SLC1A2 and SLC6A9 polymorphisms in either the entire sample or after stratification according to gender. In the haplotype analysis, men with CA haplotype had more than 1.5 higher risk to develop schizophrenia than women (OR=1.63 [95% CI=1.17–2.27, p<0.05]). The influence of gender, genotypes of both analyzed polymorphisms and gender x genotype interactions on individual dimensions of the PANSS scale has not been observed. Also, there was no association of either polymorphism with suicide attempts. Conclusion: The results of the present study did not indicate an association of polymorphism-181 A/C (rs4354668) in SLC1A2 and rs2486001 in SLC6A9 with onset of schizophrenia and its psychopathology in a Polish population. Dove 2019-04-24 /pmc/articles/PMC6499478/ /pubmed/31118638 http://dx.doi.org/10.2147/NDT.S194924 Text en © 2019 Merk et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Merk, Wojciech
Kucia, Krzysztof
Mędrala, Tomasz
Kowalczyk, Małgorzata
Owczarek, Aleksander
Kowalski, Jan
Association study of the excitatory amino acid transporter 2 (EAAT2) and glycine transporter 1 (GlyT1) gene polymorphism with schizophrenia in a Polish population
title Association study of the excitatory amino acid transporter 2 (EAAT2) and glycine transporter 1 (GlyT1) gene polymorphism with schizophrenia in a Polish population
title_full Association study of the excitatory amino acid transporter 2 (EAAT2) and glycine transporter 1 (GlyT1) gene polymorphism with schizophrenia in a Polish population
title_fullStr Association study of the excitatory amino acid transporter 2 (EAAT2) and glycine transporter 1 (GlyT1) gene polymorphism with schizophrenia in a Polish population
title_full_unstemmed Association study of the excitatory amino acid transporter 2 (EAAT2) and glycine transporter 1 (GlyT1) gene polymorphism with schizophrenia in a Polish population
title_short Association study of the excitatory amino acid transporter 2 (EAAT2) and glycine transporter 1 (GlyT1) gene polymorphism with schizophrenia in a Polish population
title_sort association study of the excitatory amino acid transporter 2 (eaat2) and glycine transporter 1 (glyt1) gene polymorphism with schizophrenia in a polish population
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499478/
https://www.ncbi.nlm.nih.gov/pubmed/31118638
http://dx.doi.org/10.2147/NDT.S194924
work_keys_str_mv AT merkwojciech associationstudyoftheexcitatoryaminoacidtransporter2eaat2andglycinetransporter1glyt1genepolymorphismwithschizophreniainapolishpopulation
AT kuciakrzysztof associationstudyoftheexcitatoryaminoacidtransporter2eaat2andglycinetransporter1glyt1genepolymorphismwithschizophreniainapolishpopulation
AT medralatomasz associationstudyoftheexcitatoryaminoacidtransporter2eaat2andglycinetransporter1glyt1genepolymorphismwithschizophreniainapolishpopulation
AT kowalczykmałgorzata associationstudyoftheexcitatoryaminoacidtransporter2eaat2andglycinetransporter1glyt1genepolymorphismwithschizophreniainapolishpopulation
AT owczarekaleksander associationstudyoftheexcitatoryaminoacidtransporter2eaat2andglycinetransporter1glyt1genepolymorphismwithschizophreniainapolishpopulation
AT kowalskijan associationstudyoftheexcitatoryaminoacidtransporter2eaat2andglycinetransporter1glyt1genepolymorphismwithschizophreniainapolishpopulation